Antibiotic sensitivity pattern and genetic variability studies of clinical isolates of lower respiratory pathogen Acinetobacter baumannii

International Journal of Pharma and Bio Sciences

Volumn 5, Issue 3, 2014, Pages

  Sundar, S K ^a   Kumari Pushpa Rani, T P ^b   Vijayalakshmi, B ^b   Murugan, M ^b  

^a MR Government Arts College   (India)

^b NOORUL ISLAM UNIVERSITY   (India)

Author keywords

A. baumannii; Antibiotic susceptibility; Genetic variability; RAPD

Indexed keywords

AMIKACIN; AMPICILLIN; CARBAPENEM; CEFEPIME; IMIPENEM; MEROPENEM; RNA 16S;

ACINETOBACTER BAUMANNII; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CLUSTER ANALYSIS; DISK DIFFUSION; DNA EXTRACTION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; LOWER RESPIRATORY TRACT; LOWER RESPIRATORY TRACT INFECTION; PHYLOGENETIC TREE; POLYMERASE CHAIN REACTION; RANDOM AMPLIFIED POLYMORPHIC DNA; SEQUENCE ANALYSIS; SPUTUM ANALYSIS; THROAT CULTURE;

EID: 84904874489     PISSN: None     EISSN: 09756299     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Peleg AY, Seifert H and Paterson DL. Acinetobacter baumannii: Emergence of a successful pathogen. Clinical Microbiology Reviews, 21(3), 538-582, (2008).
2. Rosenthal S and Tager IB. Prevalence of Gram negative rods in the normal pharyngeal flora. Ann. Intern Med, 83: 355-357, (1975).
3. Somerville DA and Noble WC. A note on the gram negative bacilli of human skin. Eur J Clin Biol Res, 40: 669-670, (1970).
4. Bergogne-Berezin E and Towner KJ. Acinetobacter spp. as Nosocomial Pathogens: Microbiological, Clinical, and Epidemiological Features. Clinical Microbiological Reviews, 148-165, (1996).
5. Tomaras AP, Dorsey CW, Edelmann RE and Actis LA. Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: involvement of a novel chaperone-usher pili assembly system. Microbiology, 149: 3473-3484, (2003).
6. Lee JC, Koerten H, Van den Broek P, Beekhuizen H, Wolterbeek R, Van den Barselaar M, Van der Reijden T, Van der Meer J, Van de Gevel J and Dijkshoorn L. Adherence of Acinetobacter baumannii strains to human bronchial epithelial cells. Res Microbiol, 157: 360-366, (2006).
7. Cevahir N, Demir M, et al. Evaluation of biofilm production, gelatinase activity, and mannose-resistant hemagglutination in Acinetobacter baumannii strains. J Microbiol Immunol Infect, 41: 513-518, (2008).
8. Gaddy JA and Actis LA. Regulation of Acinetobacter baumannii biofilm formation. Future Microbiol 4: 273-278, (2009).
9. King LB, Swiatlo E, et al. Serum resistance and biofilm formation in clinical isolates of Acinetobacter baumannii. FEMS Immunol Med Microbiol, 55: 414-421, (2009).
10. Boulanger A, Nass T, Fortineau N, Figueiredo S and Nordmann P. NDM-1-Producing Acinetobacter baumannii from Algeria. Antimicrob. Agents Chemother, 56 (4): 2214-2215, (2012).
11. Karah N, Sundsfjord A, Towner K and Samuelsen O. Insights into the global molecular epidemiology of carbapenem non-susceptible clones of Acinetobacter baumannii. Micro. Drug Resist, 15 (4): 237-247, (2012).
12. Seifert H, Boullion B, Schulze A, et al. Plasmid DNA profiles of Acinetobacter baumannii: clinical application in a complex endemic setting. Infect Control Hosp Epidemiol, 15: 520-528, (1994).
13. Cappucino and Shermann. Microbiology A Laboratory Manual; 6th Edition, (1996).p-526.
14. Forbes BA, Sahm DF and Weissfeld AS. Baily and scott's diagnostic microbiology. 12thed. Mosby, Elsevire, 334-339, (2007).
15. Bauer AW, Kirby MM, Sherris JC and Truck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol, 45:493-6, (1966).
16. CLSI, (Clinical and Laboratory Standards Institute). Performance standard for antimicrobial susceptibility testing, Twenty-First informational supplement. M100-S21.31 (1), (2011).
17. Zhao J and Meng J. Genetic analysis of loci associated with partial resistance to Sclerotinia sclerotiorum in rapeseed (Brassica napus L.). Theor Appl Genet, 106: 759-764, (2003).
18. Savov E et al. Epidemiology of Acinetobacter baumannii infections in multiprofile hospital. Trakia Journal of Sciences, 10 (2): 59-64, (2012).
19. Sundar SK and Geethu RK. Isolation, characterization and genetic variability studies of clinical isolates of Staphylococcus aureus. International Journal of Research in Biological Sciences, 1 (2): 22-26, (2011).
20. Sofia Constantiniu, Angela Romaniuc, Luminita Smaranda Iancu, Raluca Filimon and Iuliana Tarasi. Cultural and biochemical characteristics of Acinetobacter spp. strains isolated from hospital units. The journal of preventive medicine, 12 (3-4): 35-42, (2004).
21. Wayne PA: Clinical LaboratoryStandards Institute. Performance Standards for Antimicrobial Susceptibility testing; 17th Informational supplement, CLSI M2-A9. (2006).
22. Nabil Karah, Bjorg Haldorsen, Kristin Hegstad, Gunnar Skov Simonsen, Arnfinn Sundsfjord and Orjan Samuelsen. Species identification and molecular characterization of Acinetobacter spp. Blood culture isolates from Norway. Journal of Antimicrobial Chemotherapy, 66: 738-744, (2011).
23. Biswajit Maiti, Malathi Shekar, Rekha Khushiramani, Iddya Karunasagar and Indrani Karunasagar. Evaluation of RAPD-PCR and protein profile analysis to differentiate Vibrio harveyi strains prevalent along the southwest coast of India. Journal of Genetics, 88(3): 273-276, (2009).
24. Ben Othman A, Burucoa C, Battikh H, Zribi M, Masmoudi A and Fendri C. Comparison of Acinetobacter baumannii multidrugs resistant isolates obtained from French and Tunisian hospitals. Journal of Bacteriology and Parasitology, 2(1) 1-7, (2011).